Piper Sandler Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Futu NewsOct 4 20:31 · Ratings

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Altimmune (ALT) and Steris (STE)

TipRanksOct 4 20:10 · Ratings

Lilly Looking to Test Zepbound as Health Maintenance Drug: Report

Seeking AlphaOct 1 22:22

Altimmune to Participate in the H.C. Wainwright 8th Annual MASH Virtual Conference

GlobeNewswireOct 1 19:30

Roche Sees Carmot Obesity Drugs' Potential Peak Sales at $3.6B+: Report

Seeking AlphaSep 30 23:25

JMP Securities Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $24

Futu NewsSep 30 22:31 · Ratings